Keyphrases
Seroprevalence
100%
Democratic Republic of Congo
100%
Bas-Congo Virus
100%
Population-based Cross-sectional Study
100%
Neutralizing Antibodies
36%
Tibrovirus
36%
Virus
27%
Kinshasa
27%
Human Infection
18%
Virus-neutralizing Antibody
18%
Medical Research
18%
Seropositivity
18%
Japan
18%
Serosurvey
18%
Medical Product Development
18%
Population-based
9%
Survivors
9%
Virus Infection
9%
Hemorrhagic Fever
9%
Research Partnerships
9%
Increasing Prevalence
9%
Close Contact
9%
Infectious Disease Research
9%
Non-associated
9%
Serum Samples
9%
Sociodemographic Characteristics
9%
Acute Hemorrhagic
9%
Clinical Characteristics
9%
Neutralization Test
9%
Pseudovirus
9%
Venipuncture
9%
Occupational Categories
9%
Ekpoma
9%
Technology Research
9%
Molecular Survey
9%
Archived Samples
9%
Public Servants
9%
Partnerships for Sustainable Development
9%
Japan International Cooperation Agency
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neutralizing Antibody
100%
Seroprevalence
100%
Cross-Sectional Study
100%
Infection
50%
Prevalence
50%
Virus Antibody
50%
Syndrome
25%
Hemorrhagic Fever
25%
Crimean Congo Hemorrhagic Fever
25%
Diseases
25%
Medicine and Dentistry
Cross Sectional Study
100%
Seroprevalence
100%
Virus
100%
Neutralizing Antibody
36%
Infection
18%
Prevalence
18%
Virus Antibody
18%
Medical Research
18%
Neutralization
9%
Cooperation
9%
Contraindication
9%
Crimean-Congo Hemorrhagic Fever
9%
Hemorrhagic Fever
9%
Infectious Disease
9%
Vein Puncture
9%
Immunology and Microbiology
Seroprevalence
100%
Virus
100%
Neutralizing Antibody
36%
Prevalence
18%
Virus Antibody
18%
Seropositivity
18%
Infection
18%
Viral Disease
9%
Hemorrhagic Fever
9%
Neutralization
9%
Ribonucleic Acid
9%
Neuroscience
Neutralizing Antibody
100%
Virus Antibody
50%
Crimean-Congo Hemorrhagic Fever
25%